Count | |
| 5 | |
| 4 | |
| 7 | |
| 1 | |
| 1 | |
Antilipemic Agents/pharmacokinetics/*pharmacology/*therapeutic use | 1 |
Antilipemic Agents/*administration & dosage/pharmacology/therapeutic use | 1 |
| 75 | |
| 29 | |
| 1 | |
| 1 | |
| 1 | |
| 4 | |
| 1 | |
| 4 | |
| 1 | |
| 1 | |
Antilipemic Agents/adverse effects/*pharmacokinetics/therapeutic use | 1 |
| 14 | |
| 37 | |
| 1 | |
| 2 | |
| 1 | |
| 1 | |
| 2 | |
| 3 | |
Antilipemic Agents/administration & dosage/pharmacokinetics/*pharmacology | 1 |
Antilipemic Agents/*chemical synthesis/pharmacokinetics/pharmacology | 1 |
Antilipemic Agents/*chemical synthesis/chemistry/pharmacology | 1 |
| 1 | |
| 2 | |
| 1 | |
| 1 | |
| 1 | |
| 14 | |
| 1 | |
| 1 | |
| 1 | |
| 1 | |
| 1 | |
Antilipemic Agents/adverse effects/metabolism/pharmacokinetics | 1 |
Antilipemic Agents/blood/chemistry/*metabolism/pharmacokinetics | 1 |
| 5 | |
| 4 | |
| 25 | |
| 1 | |
| 2 | |
| 3 | |
| 3 | |
| 2 | |
| 8 | |
| 1 | |
| 2 | |
| 5 | |
| 1 | |
| 1 | |
| 1 | |
| 3 | |
| 6 | |
| 1 | |
| 9 | |
| 2 | |
| 2 | |
| 2 | |
| 1 | |
| 2 | |
| 9 | |
| 5 | |
| 7 | |
| 1 | |
| 3 | |
| 2 | |
| 3 | |
| 1 | |
| 1 | |
| 10 | |
| 3 | |
| 1 | |
| 11 | |
| 2 | |
| 3 | |
| 1 | |
| 1 | |
| 8 | |
| 1 | |
| 96 | |
| 3 | |
| 2 | |
| 1 | |
| 2 | |
| 2 | |
| 1 | |
| 3 | |
| 32 | |
| 9 | |
| 1 | |
| 1 | |
| 1 | |
| 2 | |
| 7 | |